Sort
23,748 grants matching “melanoma”
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
$478,020Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R01 · FY2009 · CA
Mechanisms of cell death in cutaneous melanoma
$477,822Andrew E Aplin · Thomas Jefferson University · R01 · FY2025 · CA
Mechanisms of cell death in cutaneous melanoma
$477,822Andrew E Aplin · Thomas Jefferson University · R01 · FY2021 · CA
Senescence as a Therapeutic Endpoint
$477,787Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA
Senescence as a Therapeutic Endpoint
$477,725Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA
The Adenosinergic Pathway in Tumor-derived Exosomes
$477,653Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$477,643Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$477,643Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$477,643Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Project 3: Integrative Computational Analysis of Tumor-Mediated Immunosuppression
$477,592Sylvia Katina Plevritis · Stanford University · U54 · FY2019 · CA
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
$477,421Monica Jean Justice · Baylor College Of Medicine · R01 · FY2013 · CA
Mechanical control of cell growth and differentiation
$477,379Paul A Janmey · University Of Pennsylvania · R01 · FY2010 · GM
Phase I/II study of topical agents for chemoprevention
$477,280University Of Arizona · P01 · FY2004 · CA
THE FRAMINGHAM SCHOOL STUDY OF NEVI IN CHILDREN: SONIC II
$477,113Allan C Halpern · Sloan-Kettering Inst Can Research · R56 · FY2008 · AR
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$476,960Willy Hugo · University Of California Los Angeles · R01 · FY2020 · CA
Analysis of Glycomic Regulators in Melanoma Progression
$476,815Charles J Dimitroff · Florida International University · U01 · FY2022 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$476,752Wei R. Chen · University Of Oklahoma · R01 · FY2023 · CA
Regulation of metastatic progression by an endothelial-derived factor
$476,712Sohail F. Tavazoie · Rockefeller University · R01 · FY2021 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$476,677University Of Arizona · U10 · FY2003 · CA
HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER
$476,664Battelle Pacific Northwest Laboratories · R33 · FY2003 · CA
Exploiting oxidative stress response in uveal melanoma liver metastases
$476,587Edward Hartsough · Drexel University · R01 · FY2024 · CA
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
$476,578Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · NS
Understanding the induction of T cell dysfunction in the context of lung cancer
$476,553Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2023 · CA
ENGINEERING SKIN MICROBIOME TO GENERATE NATURAL SUNSCREENS FOR PREVENTION OF MELANOMA
$476,523Cincinnati Univ Of · · FY2021 · Defense Health Agency
Pre-clinical evaluation of Magnetically labeled Cells for Cellular MRI
$476,426Joseph Frank · Clinical Center · Z01 · FY2008 · CL